BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Acetaminophen
,
rs4950928
,
SNCA
,
T cell differentiation
,
Hepatitis
,
Intestine
,
Alcohol
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
spinal muscular atrophy type III
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
DYNC1H1
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
minus-end-directed vesicle transport along microtubule
Survival motor neuron
minus-end-directed organelle transport along microtubule
positive regulation of spindle assembly
Gemini of coiled bodies
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
OMIM - Spinal muscular atrophy disorders
Mouse Phenotypes - Lower motor neuron disease
Explore Curated Studies Results
Literature
Most Relevant Literature
Sma3s: A universal tool for easy functional annotation of proteomes and transcriptomes.
Sma3s: a three-step modular annotator for large sequence datasets.
Development of new outcome measures for adult SMA type III and IV: a multimodal longitudinal study.
Type III spinal muscular atrophy mimicking muscular dystrophies.
General anesthetic management of a patient with spinal muscular atrophy type III].
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Aerobic Training in Patients With Spinal Muscular Atrophy Type III
Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Types II or III
Outcome Measures and Biomarkers in a Cohort of Spinal Muscular Atrophy Type III/ IV Patients
Clinical Assessment of Spinal Muscular Atrophy Type II and III (SMA Europe)
A Pilot Therapeutic Trial Using Hydroxyurea in Type II and Type III Spinal Muscular Atrophy Patients
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ